EWTX
EWTX
US28036F1057
Edgewise Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.24B EUR
4.38B EUR
3.39B EUR
2.64B EUR
Enterprise Value
3.8B EUR
4.31B EUR
3.36B EUR
2.58B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-21.51x
--
--
--
Price to Sales
--
--
--
--
Price to Book
9.4x
9.77x
6.86x
5.05x
EV/Revenue
--
--
--
--
EV/EBITDA
-17.55x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.18%
-3.63%
-4.4%
-4.03%
ende